The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...
Cybersecurity firm WhiteScope says it has identified cybersecurity vulnerabilities in the device ecosystems for pacemakers and implantable cardioverter-defibrillators (ICDs) across four major vendors.
Relatively weak magnets in consumer products have always posed some risk, usually very low, to the function of pacemakers and implantable cardioverter-defibrillators (ICDs). However, stronger, ...
The US Food and Drug Administration (FDA) has given Breakthrough Device Designation to Orchestra BioMed for its atrioventricular interval modulation (AVIM) therapy for patients with uncontrolled ...
Recycled pacemakers can function as well as new devices, according to a new study. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and ...
Risk of cardiac implantable electronic device (CIED) infection and resulting mortality hinged on the timing and extent of infection, which may ultimately come down to the type of procedure that the ...
Electrophysiologists are asking for better communication between their field and the interventional cardiology community, particularly with operators who perform percutaneous transcatheter tricuspid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results